Clinical Trial Update: A Study of the Safety and Efficacy of Patients With Familial Hypercholesterolaemia Taking Colesevelam as add-on Therapy to Their Existing Medication [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated the safety and efficacy of adding colesevelam to patients' existing therapy for familial hypercholesterolemia and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia

Drugs mentioned

• Welchol (colesevelam hydrochloride)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Familial Hypercholesterolemia | Phase 4 | Status: COMPLETED